November 12, 2009 12:04 PM Eastern Time

BUSINESS WIRE

Genetix Pharmaceuticals Announces Global Clinical Plans to Treat Adrenoleukodystrophy (ALD)

Marrow Transplant: How Genetix Delivers its Therapies (Graphic: Business Wire)

Marrow Transplant: How Genetix Delivers its Therapies (Graphic: Business Wire)

Opens in new window

Download

Thumbnail JPEG, 72x50, 3.0 KB
Preview JPEG, 144x102, 8.3 KB
Small JPEG, 300x213, 26.0 KB
Full Size JPEG, 1481x1054, 226.2 KB

Smart Multimedia Gallery

Marrow Transplant: How Genetix Delivers its Therapies (Graphic: Business Wire)

Marrow Transplant: How Genetix Delivers its Therapies (Graphic: Business Wire)

http://www.businesswire.com/multimedia/home/20091106005331/en/1880917/Genetix-Pharmaceuticals-Announces-Global-Clinical-Plans-Treat

View and Share Logo

Share

Email

All News | News with Multimedia > News Release: Genetix Pharmaceuticals Announces Global Clinic...